Clinical Trial Update: Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 long-term study in chronic kidney disease patients with hyperphosphatemia not on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Kidney Disease, Renal Insufficiency | Phase 3 | Status: COMPLETED